Gilead is giving a re entry point here.
AT:
Price its un compressing , has break the trendLine giving us a good RR entry.
Fundamentals:
July 22 is the earning report ,the US government has purchased all available stock of the remdesivir vaccine.
Enjoy profits , and don't forget to follow us for more ! :D